Core Viewpoint - The article discusses the launch of the "National Instrument High Quality" certification by the China Certification and Accreditation Association Testing Branch in collaboration with Beijing Xinlifang Technology Development Co., Ltd. to enhance the quality of domestic scientific instruments and address the "bottleneck" issues in the industry [2]. Group 1 - The initiative aims to promote the development of high-quality domestic scientific instruments and enhance the industry's independent innovation capabilities [2]. - A joint working group for the "National Instrument High Quality" certification has been established to utilize certification methods for the high-quality development of domestic instruments [2]. - The Beijing High-end Scientific Instrument Innovation Development Action Plan (2025-2027) encourages product certification to improve reliability and stability, facilitating technological iteration and quality upgrades in high-end scientific instruments [2]. Group 2 - Eligible domestic scientific instrument manufacturers can submit applications for the "National Instrument High Quality" certification based on their product models [3]. - The article provides contact information for inquiries regarding the certification application process [4].

MatTek 是全球领先的人体细胞微组织与三维模型开发和制造商，致力于加速药物开发进程。其先进的细胞模型模拟人体组织的结构和功能， 相较传统的二维细胞培养，能够提供更精准、更具成本效益且可重现的结果，同时减少动物实验需求。MatTek拥有80余名员工，总部位于美 国马萨诸塞州阿什兰市，在斯洛伐克的布拉迪斯拉发设有生产基地。 导读： 通过将其并入实验室产品与服务板块，赛多利斯进一步扩充其细胞技术产品线，并与现有的药物开发解决方案形成协同效应，包括细胞分析仪器、试剂和 AI模型。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 赛多利斯于2 0 2 5年7月1日正式完成对BICO集团旗下Ma tTe k公司，包括Visi k o l的收购。通过将其并入实验室产品与服务板块，赛多利斯进一 步扩充其细胞技术产品线，并与现有的药物开发解决方案形成协同效应，包括细胞分析仪器、试剂和AI模型。 点击文末"阅读原文"查看详情 | 版 权 ： 本 文 部 分 素 材 源 自 网 络 ， 版 权 归 原 作 者 所 有 ， 观 点 代 表 作 者 本 人 ， ...

Core Viewpoint - The Henan Provincial Science and Technology Department announced a funding plan of 31.22 million yuan for 27 projects in three major areas, with a focus on the purchase of scientific research instruments and equipment, which constitutes the core direction of this funding support [1]. Group 1: Funding Allocation - A total of 31.22 million yuan will be allocated to support 27 projects aimed at enhancing the research infrastructure in Henan Province [1]. - The funding is primarily directed towards the purchase of scientific research instruments, with 18.65 million yuan allocated to 13 projects in this category, making it the dominant area of investment [3]. Group 2: Project Categories - The funding is divided into three main categories: 1. **Shared Platform Construction**: 8 projects with a total funding of 9.4 million yuan, including various genetic resource libraries [2]. 2. **Research Facility Renovation**: 6 projects with a total funding of 3.17 million yuan, focusing on upgrading and repairing research buildings [3]. 3. **Scientific Instrument Purchase**: 13 projects with a total funding of 18.65 million yuan, aimed at acquiring advanced testing and analysis systems [3]. Group 3: Specific Projects and Funding - Notable projects under the scientific instrument purchase category include: - Food and drug quality safety testing system: 1.4 million yuan [3]. - High-throughput precise analysis system for volatile substances: 1.6 million yuan [3]. - Automated culture and detection system for organoids: 1.6 million yuan [3]. - The shared platform construction includes projects like the establishment of various genetic resource libraries, each receiving funding of 100,000 yuan [2].

Core Viewpoint - Tianjin University has announced procurement intentions for 30 items of scientific instruments and equipment, with a total budget of 105 million yuan, scheduled for procurement between December 2024 and August 2025 [1][2]. Summary by Categories Procurement Overview - The procurement includes various advanced instruments such as Atomic Force Microscopes, Laser Flash Apparatus, and Thermal Scanning Probes, with a total budget of 105 million yuan [1][2]. Instrument Descriptions - **Electron Backscatter Diffraction (EBSD)**: Analyzes the microstructure of crystalline materials by detecting diffraction patterns from backscattered electrons [3]. - **Full-Function Steady-State and Transient Fluorescence Spectrometer**: Supports both steady-state and transient fluorescence measurements, widely used in chemistry, physics, materials science, biology, and environmental science [3]. - **Laser Flash Apparatus (LFA)**: Measures thermal diffusivity and calculates thermal conductivity of materials using a laser pulse [3]. - **Atomic Force Microscope (AFM)**: Provides high-resolution 3D imaging and mechanical property analysis of materials at the nanoscale [5]. - **Low-Temperature Probe Station**: Characterizes electrical properties of materials at low temperatures, essential for carbon-based integrated circuit research [6]. - **Energy Dispersive Spectroscopy and EBSD**: Used for elemental composition and chemical state characterization of materials [6]. - **Scanning Tunneling Microscope (STM)**: Offers high-resolution observation of low-dimensional materials' surface structures and electronic properties [7]. - **Thermal Scanning Probe**: Investigates fundamental properties of materials by localized heating [7]. Detailed Procurement List - The procurement list includes specific instruments with their respective budgets and intended procurement dates, such as: - **Ellipsometer**: 1 unit, budget of 1.37 million yuan, procurement in July 2025 [6]. - **Atomic Force Microscope**: 1 unit, budget of 2.16 million yuan, procurement in July 2025 [6]. - **Laser Flash Apparatus**: 1 unit, budget of 1.36 million yuan, procurement in July 2025 [7]. - **Thermoelectric Testing System**: 1 unit, budget of 1.30 million yuan, procurement in July 2025 [7]. - **Plasma Etching Machine**: 1 unit, budget of 1.20 million yuan, procurement in December 2024 [12].

Core Viewpoint - The acquisition of FARO Technologies by AMETEK for $920 million (approximately 6.6 billion RMB) marks a significant strategic move in the high-end 3D measurement technology sector, enhancing AMETEK's capabilities and market position [1][3]. Group 1: Acquisition Details - AMETEK announced the acquisition of FARO Technologies at a cash price of $44 per share, representing a premium of approximately 40% over FARO's closing price on May 5, 2025 [1]. - The acquisition has been approved by FARO's shareholders and all regulatory bodies, leading to the delisting of FARO's common stock from NASDAQ [1]. Group 2: Market Impact - This acquisition is expected to have a profound impact on the global 3D measurement industry, positioning AMETEK more competitively against major players like Hexagon and Zeiss [3]. - The 3D measurement market was valued at $9.93 billion in 2021 and is projected to grow to $14.46 billion by 2026, with a compound annual growth rate (CAGR) of 7.88% [3]. Group 3: Company Profiles - FARO Technologies is a leading provider of 3D measurement and imaging solutions, with annual sales of approximately $340 million, serving various end markets including manufacturing, construction, and public safety [2]. - Following the acquisition, FARO will become part of AMETEK's Electronic Instruments Group (EIG) under its ultra-precision technology division [2][4]. Group 4: Strategic Rationale - The acquisition is not only a financial investment but also a strategic move to enhance technological capabilities and customer resource integration, making AMETEK more competitive in the precision measurement sector [3][4]. - FARO's innovations in laser scanning and high-precision portable devices will provide AMETEK with greater research and development investment and global market expansion capabilities [4].

Group 1 - The core viewpoint of the article emphasizes Suzhou's focus on three main directions: industrial instruments, scientific instruments, and specialized instruments, aiming to strengthen six key advantageous areas and optimize the industrial system with 18 specific tasks, targeting a scale of over 150 billion yuan for high-end scientific instruments by 2027, maintaining the top position in the country [1][3] Group 2 - On July 21, the municipal government held an executive meeting to review and approve the "Suzhou AI Chip Industry Innovation Development Three-Year Action Plan (2025-2027)" and related measures, aiming for the AI chip industry scale to exceed 50 billion yuan by 2027, with over 30 industrialization projects introduced and more than 10 innovative products filling domestic gaps [2] - The "Quality Suzhou" construction action plan was also approved, focusing on quality branding, market expansion, and growth promotion, with 18 key tasks across six areas to comprehensively advance the "Quality Suzhou" initiative [2]

Core Viewpoint - Sartorius reported a sales revenue of €1.767 billion for the first half of 2025, marking a year-on-year growth of 6.1%, primarily driven by the bioprocess solutions segment and laboratory products and services [3][4]. Group 1: Financial Performance - The company achieved a sales revenue growth of 6.1% in the first half of 2025 [4]. - The bioprocess solutions segment generated €1.435 billion, with a year-on-year growth of 8.8% [4]. - The laboratory products and services segment reported a revenue of €332 million, showing a decline of 4.0% when adjusted for fixed exchange rates [5]. Group 2: Business Segments - The bioprocess solutions segment is expected to grow approximately 7% for the full year 2025, supported by a rich product portfolio that enhances drug production efficiency [6]. - The laboratory products and services segment is projected to grow about 1% for the full year 2025, with new products aimed at accelerating drug development [6]. Group 3: Management Outlook - The management confirmed the full-year guidance for 2025, anticipating an organic sales revenue growth of around 6% [6]. - The CEO expressed satisfaction with the first half performance and emphasized the importance of high-margin consumables in the pharmaceutical sector [4].

Core Viewpoint - ShanghaiTech University has announced procurement intentions for 26 items of scientific instruments and equipment, with a total budget of 147 million yuan, expected to be purchased between May and October 2025 [1][2]. Summary by Relevant Sections Procurement Overview - The procurement includes items such as medium-caliber optical adjustment frames, auxiliary adjustment laser devices, large-caliber optical components, plasma electro-optical switches, liquid nitrogen pipelines and control systems, and plasma liner gun transmission systems [2][3]. Budget and Timeline - The total budget for the procurement is 147 million yuan, with the expected procurement period set for May to October 2025 [1][2]. Specific Equipment Details - The procurement list includes: - Medium-caliber optical adjustment frame for hard X-ray free electron laser device construction, budgeted at 2 million yuan [4]. - Auxiliary adjustment laser device, budgeted at 1.9 million yuan [4]. - Large-caliber optical components, budgeted at 4 million yuan [4]. - Plasma electro-optical switches, budgeted at 2 million yuan [5]. - Liquid nitrogen pipelines and control systems, budgeted at 2 million yuan [5]. - Plasma liner gun transmission systems, with various components and specifications detailed [6][7][8]. Technical Specifications - The procurement includes advanced technical specifications for each item, such as: - Plasma liner gun systems with specific parameters for operational lifespan, electrical resistance, and material requirements [6][7]. - High-resolution spectrometers and scanning spectroscopic systems for plasma diagnostics [7][8]. - Various vacuum systems and components designed for ultra-high vacuum environments, with stringent performance criteria [8][9]. Delivery and Warranty - Delivery timelines for the equipment range from 2 months to 24 months, with warranty periods typically set at 1 year, and some items having extended warranty periods [6][8][9].

特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我 们的推送。 7 月23日，上海泰坦科技股份有限公司发布《关于拟收购境外公司股权并签署股权收购协议的 公告》。 | 视 觉 ： 长 艳 柱 子 | 版 权 ： 本 文 部 分 素 材 源 自 网 络 ， 版 权 归 原 作 者 所 有 ， 观 点 代 表 作 者 本 人 ， 不 代 表 本 号 立 场 Apol lo Scientific最初成立于1993年，当时名为M&G Chemical s Limited，并在1996年 更名为Apol lo Scientific Limited，同时迁移到位于英格兰曼彻斯特附近的斯托克波特的一 个 170 平 方 米 的 商 务 中 心 。 通 过 为 英 国 和 欧 洲 的 一 些 小 型 国 际 制 造 商 进 行 销 售 和 市 场 营 销 ， Apol lo Scientific逐步扩大了其业务范围。 | 转 载 ： 须 本 号 授 权 ， 请 联 系 主 编 | 来 源 ： 互 联 网 | 责 编 ： 满 满 本次交易将助力泰坦公司拓展海外渠道、丰富产品 ...

Group 1 - The core viewpoint of the article is that Mindray Medical, a mainland medical device manufacturer listed in A-shares, is considering a secondary IPO in Hong Kong, aiming to raise at least $1 billion (approximately 7.8 billion HKD) [1] - Mindray Medical has engaged potential advisors to discuss the possible share issuance, positioning itself to become one of the largest mainland companies seeking a second listing in Hong Kong [1] - If successful, this Hong Kong listing will further solidify Mindray's position in the international market and accelerate its globalization process, providing additional funds for R&D innovation and technology upgrades to better serve global healthcare demands [1]